.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Fish and Richardson
Cantor Fitzgerald
Baxter
Cipla
Daiichi Sankyo
Fuji
QuintilesIMS
Queensland Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 015230

« Back to Dashboard

NDA 015230 describes AMICAR, which is a drug marketed by Clover Pharms and is included in three NDAs. It is available from three suppliers. Additional details are available on the AMICAR profile page.

The generic ingredient in AMICAR is aminocaproic acid. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.

Summary for 015230

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 015230

Physiological EffectDecreased Fibrinolysis

Medical Subject Heading (MeSH) Categories for 015230

Suppliers and Packaging for NDA: 015230

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMICAR aminocaproic acid SYRUP;ORAL 015230 NDA Clover Pharmaceuticals Corp. 49411-052 49411-052-08 236.5 mL in 1 BOTTLE, PLASTIC (49411-052-08)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength1.25GM/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
McKesson
Baxter
Medtronic
US Army
Boehringer Ingelheim
Chubb
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot